New study data suggests 'long COVID” involves four distinct conditions

Gift supports physical medicine and rehabilitation research, honors Joseph Dragonette

RUSH group trains public in CPR, Narcan use and more

After successful surgery, Sam learned a valuable lesson

A RUSH expert identifies stroke risk factors that you may not be aware of

Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.

Student honorees selected by faculty, staff and classmates were recognized at the annual Awards Ceremony and Commencement Banquet

A cure to hepatitis C is within reach

Even moderate drinking isn’t good for you. So how much is?

Skin cancer is often deadlier when found in people with dark skin, so know your risks